GASTROENTEROPANCREATIC NEC (GEP NEC)

Clinical trials for GASTROENTEROPANCREATIC NEC (GEP NEC) explained in plain language.

Never miss a new study

Get alerted when new GASTROENTEROPANCREATIC NEC (GEP NEC) trials appear

Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEC (GEP NEC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Radioactive 'Magic Bullet' tested against tough cancers

Disease control Recruiting now

This study is testing a new radioactive drug called [212Pb]Pb-DOTAM-MAM279 in adults with advanced small cell lung cancer and other hard-to-treat solid tumors. The main goals are to find a safe and effective dose and to see if the treatment can shrink tumors. The drug is designed…

Matched conditions: GASTROENTEROPANCREATIC NEC (GEP NEC)

Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

GASTROENTEROPANCREATIC NEC (GEP NEC)

Get alerted when new GASTROENTEROPANCREATIC NEC (GEP NEC) trials appear

Radioactive 'Magic Bullet' tested against tough cancers